Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial

Published:2019-03-25 Issue:4 Volume:6 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Petchkum Porkaew¹,Sungkanuparph Somnuek²,Kiertiburanakul Sasisopin¹,Phuphuakrat Angsana¹^ORCID

Affiliation:

1. Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

2. Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand

Funder

Faculty of Medicine Ramathibodi Hospital

Mahidol University

Thai AIDS Society

Thailand Research Fund

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/6/4/ofz155/28530453/ofz155.pdf

Reference25 articles.

1. The Bureau of AIDS, TB and STI, Department of Disease Control, Thailand. Thailand national guidelines on HIV/AIDS treatment and prevention. 2017. Available at: http://www.thaiaidssociety.org/index.php?option=com_content&view=article&id=79&Itemid=86. Accessed 5 March 2019.

2. Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral therapy: A systematic review and meta-analysis of randomized trials;Ford;J Acquir Immune Defic Syndr,2015

3. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial;Cohen;Lancet,2011

4. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial;Molina;Lancet,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV;AIDS Research and Human Retroviruses;2022-06-01

2. Use of rilpivirine in HIV-1-infected individuals in routine clinical practice from 2012 to 2017 in France;Journal of Antimicrobial Chemotherapy;2020-12-05

3. Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up;HIV Research & Clinical Practice;2019-11-02

4. Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment;Expert Opinion on Drug Metabolism & Toxicology;2019-10-03